Synergy Healthcare plc Rating Lowered to Reduce at Numis Securities Ltd (SYR)
Synergy Healthcare plc (LON:SYR) was downgraded by stock analysts at Numis Securities Ltd to a “reduce” rating in a report issued on Friday. They currently have a GBX 1,360 ($22.57) price objective on the stock, down from their previous price objective of GBX 1,380 ($22.90). Numis Securities Ltd’s price target would indicate a potential downside of 9.96% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of Synergy Healthcare plc in a research note on Tuesday. They now have a GBX 1,646 ($27.31) price target on the stock. Separately, analysts at Investec raised their price target on shares of Synergy Healthcare plc from GBX 1,565 ($25.97) to GBX 1,607 ($26.67) in a research note on Thursday, August 14th. They now have a “buy” rating on the stock. Finally, analysts at N+1 Singer raised their price target on shares of Synergy Healthcare plc from GBX 1,258 ($20.88) to GBX 1,283 ($21.29) in a research note on Thursday, July 31st. They now have a “hold” rating on the stock. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of GBX 1,351.29 ($22.42).
Shares of Synergy Healthcare plc (LON:SYR) opened at 1505.00 on Friday. Synergy Healthcare plc has a 1-year low of GBX 991.00 and a 1-year high of GBX 1529.00. The stock has a 50-day moving average of GBX 1426. and a 200-day moving average of GBX 1353.. The company’s market cap is £886.4 million.
Synergy Health plc and its subsidiaries deliver a range of specialist outsourced services to healthcare providers and other customers concerned with health management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.